Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
April 08, 2024
This CGD Note outlines a proposal for a New Compact between Gavi and partner countries. We outline a package of policy shifts for Gavi to consider, in line with the core approach of prioritising country ownership and financing of the highest priority vaccines while health aid is provided at the marg...
Blog Post
February 22, 2024
The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve antibiotic resistance, it’s not enough to solve just some of these. If we fix the market failures that reduce the number of new antibiotics that are discovered, but not t...
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
Blog Post
September 27, 2023
The UK is, hopefully, coming out of its nadir in international development. This is marked by planned rises in development spend, an ambitious new international development white paper, a supportive Minister, and a new parliament in 2024. But before considering any proposal, future governments with ...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 22, 2023
A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...
CASE STUDIES
June 01, 2023
For the last three decades, Zambia has implemented a series of policies to gradually work towards Universal Health Coverage (UHC). This case study delves into the process followed by the government of Zambia in developing those policies, with the aim of supporting other countries embarking on the jo...
Blog Post
June 01, 2023
No longer the new kid on the block, Effective Altruism (EA) has evolved from its early days in the quadrangles of the University of Oxford to become a thriving community with a well-established architecture of philanthropic institutions. EA organisations now marshal resources in the hundreds of mill...
Blog Post
April 25, 2023
This month, Ghana and Nigeria became the first two countries to approve the use of R21, a vaccine that may have game-changing effectiveness in protecting people from malaria. The emergence of effective vaccines promises a new golden age of success in the fight against malaria, just as such efforts h...